FDA 503B outsourcing facilities in Mississippi
Mississippi has 1 FDA-registered 503B outsourcing facility in the PeptideGrids directory, none with FDA drug recalls on record, the earliest registered in 2014. 503B facilities compound sterile medications in bulk under FDA cGMP standards and are a primary supply route for compounded peptides and GLP-1s during drug shortages.
| Facility | City | FDA-registered since | FDA recalls |
|---|---|---|---|
| Delta Pharma, Inc. | Ripley | 2014 | None on record |
503B compounding in Mississippi
A 503B outsourcing facility registers with the FDA under the Drug Quality and Security Act and is inspected against cGMP manufacturing standards. In addition to that federal registration, a facility shipping into or operating in Mississippi must hold the appropriate state pharmacy license. Verify any facility's current license with the Mississippi Board of Pharmacy.
Peptides and GLP-1s compounded in Mississippi
Facilities in Mississippi report compounding Semaglutide to the FDA. PeptideGrids grades the clinical evidence for each. Browse the full GLP-1 and therapeutic peptide databases.
Frequently asked questions
How many FDA 503B outsourcing facilities are in Mississippi?
1 FDA-registered 503B outsourcing facility is listed in Mississippi on PeptideGrids, the earliest registered in 2014.
Which Mississippi 503B facilities have FDA recalls on record?
None of the Mississippi facilities in our directory have FDA drug recalls on record.
How do I verify a pharmacy license in Mississippi?
Use the Mississippi Board of Pharmacy license lookup to confirm a facility's current license status.
Facilities sourced from the FDA registered outsourcing facilities list. Recall counts from the FDA openFDA drug enforcement database.